1.Topical Glycopirrolate for the Management of Hyperhidrosis in Herpetic Neuralgia.
Nebojsa Gojko LADJEVIC ; Ivana Spasoje LIKIC-LADJEVIC
Yonsei Medical Journal 2009;50(2):293-295
Herpes zoster is a relapse of varicella. In certain cases, long-term pain and hyperhidrosis have been noted. Appearance of herpes zoster during pregnancy is infrequent. We described hyperhidrosis and pain treatment using glycopirrolate cream in a pregnant woman with herpetic neuralgia. A 32 year old woman, 21 weeks pregnant with second child, complained to her gynecologist of the appearance of a vesicular rash on the left half of the forehead that progressed toward her left eyelid, accompanied by lancinating pain, allodynia, hyperhidrosis and small edema, blepharitis and conjunctivitis. Following clinical and laboratory tests, she was diagnosed with herpes zoster ophtalmicus. Aciclovir therapy was administered 800 mg orally five times daily for seven days. Pain therapy was initiated with amitriptilline. We discontinued amitriptilline therapy after 10 days because of appearance of unwanted side effects. After skin changes ceased, we introduced Lidocaine patch into pain therapy which reduced the allodynia, but not the lancinating pain and hyperhidrosis. At that time we began using glycopirrolate cream which reduced pain intensity by 28.5% within 24 hours, and completely eliminated hyperhidrosis. After 48 hours of use, the pain completely disappeared. During the Glycopirrolate cream therapy, there were no side effects. This is a first report to document that a topical Glycopirrolate cream has a beneficial effect in a patient with hyperhidrosis and herpetic neuralgia.
Adjuvants, Anesthesia/administration & dosage/*therapeutic use
;
Administration, Topical
;
Adult
;
Female
;
Glycopyrrolate/administration & dosage/*therapeutic use
;
Herpes Zoster/*drug therapy/pathology
;
Humans
;
Neuralgia/pathology/*physiopathology
;
Pregnancy
2.Ramsay Hunt Syndrome Complicated by Brainstem Encephalitis in Varicella-zoster Virus Infection.
Yao-Yao SHEN ; Ting-Min DAI ; Hai-Ling LIU ; Wei WU ; Jiang-Long TU
Chinese Medical Journal 2015;128(23):3258-3259
Acyclovir
;
therapeutic use
;
Anti-Inflammatory Agents
;
therapeutic use
;
Antiviral Agents
;
therapeutic use
;
Brain Stem
;
pathology
;
virology
;
Encephalitis
;
complications
;
diagnosis
;
drug therapy
;
virology
;
Herpes Zoster
;
complications
;
diagnosis
;
drug therapy
;
virology
;
Herpes Zoster Oticus
;
diagnosis
;
drug therapy
;
etiology
;
virology
;
Humans
;
Male
;
Methylprednisolone
;
therapeutic use
;
Middle Aged
3.Disseminated superficial actinic porokeratosis like drug eruption: a case report.
Sang Min HWANG ; Eung Ho CHOI ; Sung Ku AHN
Journal of Korean Medical Science 1999;14(2):227-229
We report a 54-year-old male patient who developed an unusual form of generalized drug eruption. He had pain and breathlessness on the left chest wall. He had history of taking several drugs at private clinics under a diagnosis of herpes zoster. Two weeks later he had a generalized skin eruption. Examination showed multiple variable sized, mild pruritic, erythematous macules and papules on the face and upper extremities. Skin lesions take the form of a clinically consistent with disseminated superficial actinic porokeratosis (DSAP). Methylprednisolone 16 mg, astemisole 10 mg, oxatomide 60 mg was prescribed. Topical corticosteroid cream was applied. Within two months, his eruption had cleared almost completely. The pathogenetic mechanisms of this case are unclear, but drug and UV light have been considered.
Case Report
;
Drug Eruptions/physiopathology
;
Drug Eruptions/etiology*
;
Drug Eruptions/drug therapy
;
Facial Dermatoses/pathology
;
Facial Dermatoses/drug therapy
;
Facial Dermatoses/chemically induced*
;
Hand Dermatoses/pathology
;
Hand Dermatoses/drug therapy
;
Hand Dermatoses/chemically induced*
;
Herpes Zoster/complications*
;
Human
;
Male
;
Middle Age
;
Porokeratosis/pathology
;
Porokeratosis/drug therapy
;
Porokeratosis/chemically induced*